Coombs test; Covid-19; anemia; hemolysis; iron metabolism; Hematology
Abstract :
[en] [en] BACKGROUND: For more than 2 years medical practice has been dealing with the Covid-19 pandemic. Atypical symptoms, such as frostbites and acrosyndromes, have appeared, and autoimmune anemias (some of which with cold agglutinins) have been described.
OBJECTIVES: We planned to study the prevalence of positive direct Coombs tests (DCTs) and hemolytic autoimmune anemia in patients infected with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and its correlation with complications, and then investigate the impact of the infection on iron metabolism.
DESIGN: This is an observational, cross-sectional, single-center, exploratory study.
METHODS: We obtained Coombs tests in a population of 179 infected patients at the CHU of Liège. We then studied iron metabolism in some of these patients, by measuring serum ferritin, erythropoietin (EPO), erythroferrone and hepcidin.
RESULTS: We did not identify any case of autoimmune hemolysis. However, there was a 20.3% prevalence of positive DCT, mainly with IgG (91.7%). These patients, compared to DCT-negative patients, were not only more anemic and transfused, but also required more transfers to intensive care units and had longer hospital stays and mechanical ventilation. The pattern of anemia was consistent with the anemia of inflammation, showing elevated hepcidin and ferritin levels, while EPO and erythroferrone values were lower than expected at this degree of anemia. Erythroferrone was higher and Hb was lower in DCT-positive patients. Finally, we identified a correlation between iron parameters and complicated forms of infection.
CONCLUSION: Covid-19 patients suffered from inflammatory anemia with more severe forms of infection correlated to positive DCT status. This could potentially be of interest for future clinical practice.
Disciplines :
Hematology
Author, co-author :
Schmitz, Léa ; Centre Hospitalier Universitaire de Liège - CHU > > Service d'hématologie clinique
Pirotte, Michelle ; Centre Hospitalier Universitaire de Liège - CHU > > Service d'hématologie clinique
Lebeau, Alizée ; Université de Liège - ULiège > Département des sciences biomédicales et précliniques > Biologie cellulaire et moléculaire
Ernst, Marie ; Centre Hospitalier Universitaire de Liège - CHU > > Service des informations médico économiques (SIME)
Fillet, Marianne ; Université de Liège - ULiège > Département de pharmacie > Analyse des médicaments
DEVEY, Anaïs ; Centre Hospitalier Universitaire de Liège - CHU > > Service d'hématologie biologique et immuno-hématologie
SCHMITT, Justine ; Centre Hospitalier Universitaire de Liège - CHU > > Service d'hématologie biologique et immuno-hématologie
Cobraiville, Gaël ; Centre Hospitalier Universitaire de Liège - CHU > > Service de rhumatologie
BINSFELD, Marilène ; Centre Hospitalier Universitaire de Liège - CHU > > Service d'hématologie biologique et immuno-hématologie
Gofflot, Stéphanie ; Centre Hospitalier Universitaire de Liège - CHU > > Biothèque Hospitalo-Universitaire de Liège (BHUL)
Beguin, Yves ✱; Centre Hospitalier Universitaire de Liège - CHU > > Service d'hématologie clinique
Vertenoeil, Gaëlle ✱; Centre Hospitalier Universitaire de Liège - CHU > > Service d'hématologie clinique
✱ These authors have contributed equally to this work.
Language :
English
Title :
Alterations of erythropoiesis in Covid-19 patients: prevalence of positive Coombs tests and iron metabolism.
Lazarian G Quinquenel A Bellal M, et al. Autoimmune hemolytic anemia associated with Covid-19 infection. Br J Haematol 2020; 190: 29–31.
Hassler P Andrès E. Immune thrombocytopenic purpura in a patient with Covid-19. N England J Med 2020; 382: e43.
Patil NR Herc ES Girgis M. Cold agglutinin disease and autoimmune hemolytic anemia with pulmonary embolism as a presentation of COVID-19 infection. Hematol Oncol Stem Cell Ther 2022; 15: 213–216.
Zagorski E Pawar T Rahimian S, et al. Cold agglutinin autoimmune hemolytic anemia associated with novel coronavirus (COVID-19). Br J Haematol 2020; 190: e183–e184.
Wollina U. Challenges of Covid-19 pandemic for dermatology. Dermatol Ther 2020; 33: e13430.
Berentsen S. New insights in the pathogenesis and therapy of cold agglutinin-mediated autoimmune hemolytic anemia. Front Immunol 2020; 11: 590.
Gralinski LE Sheahan TP Morrison TE, et al. Complement activation contributes to severe acute respiratory syndrome coronavirus pathogenesis. MBio 2018; 9: e01753-18.
Magro C Justin Mulvey J Berlin D, et al. Complement associated microvascular injury and thrombosis in the pathogenesis of severe COVID-19 infection: a report of five cases. Transl Res 2020; 220: 1–13.
Campbell CM Kahwash R. Will complement inhibition be the new target in treating COVID-19 related systemic thrombosis? Circulation 2020; 141: 1739–1741.
Li Q Chen Z. An update: the emerging evidence of complement involvement in COVID-19. Med Microbiol Immunol 2021; 210: 101–109.
Berzuini A Bianco C Paccapelo C, et al. Red cell-bound antibodies and transfusion requirements in hospitalized patients with COVID-19. Blood 2020; 136: 766–768.
Kautz L Jung G Valore EV, et al. Identification of erythroferrone as an erythroid regulator of iron metabolism. Nat Genet 2014; 46: 678–684.
Von Elm E Altman DG Egger M, et al. Strenghtening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. BMJ 2007; 335: 806–808.
Jaspers A Baron F Willems E, et al. Serum hepcidin following autologous hematopoietic cell transplantation: an illustration of the interplay of iron status, erythropoiesis and inflammation. Haematologica 2014; 99: e35–e37.
Pirotte M Fillet M Seidel L, et al. Erythroferrone and hepcidin as mediators between erythropoiesis and iron metabolism during allogenic hematopoietic stem cell transplant. Am J Hematol 2021; 96: 1275–1286.
Saini AS Shayani K Schwartz J. Cold agglutinin hemolytic anemia induced by COVID-19. Am J Med Case Rep 2021; 9: 328–330.
Gupta R Singh S Anusim N, et al. Coronavirus disease 2019 and cold agglutin syndrome: an interesting case. Eur J Case Rep Intern Med 2021; 8: 002387.
Algassim AA Elghazaly AA Alnahdi AS, et al. Prognostic significance of hemoglobin level and autoimmune hemolytic anemia in SARS-CoV-2 infection. Ann Hematol 2021; 100: 37–43.
Hafez W Azzam Ziade M Arya A, et al. The significance of antiglobulin (Coombs) test reactivity in patients with COVID-19. Immunobiology 2022; 227: 152240.
Hendrickson JE Tormey CA. COVID-19 and the Coombs test. Blood 2020; 136: 655–656.
Kisserly A Schneider N Audonnet S, et al. Acquired decrease of the C3b/C4b receptor (CR1, CD35) and increased C4d deposits on erythrocytes from ICU COVID-19 patients. Immunobiology 2021; 226: 152093.
Bergamaschi G Borrelli de Andreis F Aronico N, et al. Anemia in patients with Covid-19: pathogenesis and clinical significance. Clin Exp Med 2021; 21: 239–246.
Weis G Ganz T Goodnough LT. Anemia of inflammation. Blood 2019; 133: 40–50.
Cazzola M Beguin Y Bergamaschi G, et al. Soluble transferrin receptor as a potential determinant of iron loading in congenital anaemias due to ineffective erythropoiesis. Br J Haematol 1999; 106: 752–755.
R’Zik S Beguin Y. Serum soluble transferrin receptor concentration is an accurate estimate of the mass of tissue receptors. Exp Hematol 2001; 29: 677–685.
Maira D Duca L Busti F, et al. The role of hypoxia and inflammation in the regulation of iron metabolism and erythropoiesis in COVID-19: the IRONCOVID study. Am J Hematol 2022; 97: 1404–1412.
Taneri PE Gómez-Ochoa SA Llanaj E, et al. Anemia and iron metabolism in COVID-19: a systematic review and meta-analysis. Eur J Epidemiol 2020; 35: 763–773.
Zhou C Chen Y Ji Y, et al. Increased serum levels of hepcidin and ferritin are associated with severity of COVID-19. Med Sci Monit 2020; 26: e926178.
Hippchen T Altamura S Muckenthaler MU, et al. Hypoferremia is associated with increased hospitalization and oxygen demand in COVID-19 patients. Hemasphere 2020; 4: e492.
Nai A Ivan Lorè N Pagani A, et al. Hepcidin levels predict Covid-19 severity and mortality in a cohort of hospitalized Italian patients. Am J Hematol 2021; 96: E3.
Frost JN Hamilton F Arnold D, et al. Evaluation of perturbed iron-homeostasis in a prospective cohort of patients with Covid-19. Wellcome Open Res 2022; 7: 173.
